Unconfigured Ad
Collapse
X
-
-
I hadn't actually seen it before, but it is a very good looking web app! The power estimates should be similar, but won't be identical for 2 reasons:
1. Scotty assumes that variance follows a lognormal distribution. I think this is a valid and logical assumption. RNASeqPower uses the measured variance from the data instead.
2. Scotty pseudo-randomly selects 200 values from a 2 dimensional matrix (variance and depth) then uses that mean as the power of the dataset. The way we use RNASeqPower is to say that we want to know the minimum requirements to reach the desired power. We need to know two things, how many genes do I want to detect and how much variance to I want to allow. If you only want to detect the top 90% of genes, then you take the 10th percentile of gene counts for your pilot (all other genes will have more than this count). You do the same for variance except you select the 90th percentile of variance. Using the minimum read count and the maximum allowable variance, that is the power you have in your experiment. Granted most genes will have higher power since they will have lower variance and higher counts. So in the end, it comes down to how you define what power actually means.
RNASeqPower can also give you the power for each gene in a dataset.
Comment
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 10-22-2026, 11:13 AM
|
0 responses
25 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 11:13 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 10:48 AM
|
0 responses
20 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 10:48 AM
|
||
|
Started by SEQadmin2, 10-15-2026, 10:52 AM
|
0 responses
36 views
0 reactions
|
Last Post
by SEQadmin2
10-15-2026, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
42 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
Comment